Allogene Therapeutics (ALLO) Other Non Operating Income (2019 - 2025)
Historic Other Non Operating Income for Allogene Therapeutics (ALLO) over the last 7 years, with Q3 2025 value amounting to -$81000.0.
- Allogene Therapeutics' Other Non Operating Income rose 9279.36% to -$81000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.0 million, marking a year-over-year increase of 7771.29%. This contributed to the annual value of -$3.9 million for FY2024, which is 7802.07% up from last year.
- As of Q3 2025, Allogene Therapeutics' Other Non Operating Income stood at -$81000.0, which was up 9279.36% from -$43000.0 recorded in Q2 2025.
- In the past 5 years, Allogene Therapeutics' Other Non Operating Income registered a high of $2.1 million during Q1 2023, and its lowest value of -$6.9 million during Q4 2023.
- Its 5-year average for Other Non Operating Income is -$1.5 million, with a median of -$929000.0 in 2024.
- Per our database at Business Quant, Allogene Therapeutics' Other Non Operating Income tumbled by 65122.41% in 2022 and then soared by 12502.73% in 2023.
- Over the past 5 years, Allogene Therapeutics' Other Non Operating Income (Quarter) stood at -$1.8 million in 2021, then tumbled by 101.27% to -$3.6 million in 2022, then plummeted by 90.65% to -$6.9 million in 2023, then skyrocketed by 71.85% to -$2.0 million in 2024, then soared by 95.85% to -$81000.0 in 2025.
- Its last three reported values are -$81000.0 in Q3 2025, -$43000.0 for Q2 2025, and $92000.0 during Q1 2025.